Terms: = Uterine cancer AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4
86 results:
1. Significance of platelet parameters in invasive squamous cell carcinoma of uterine cervix.
Anand A; Raju K
J Cancer Res Ther; 2024 Jan; 20(1):139-143. PubMed ID: 38554311
[TBL] [Abstract] [Full Text] [Related]
2. uterine Fibroid Prevalence in a Predominantly Black, Chicago-Based Cohort.
Ndebele S; Turner T; Liao C; Aschebrook-Kilfoy B; Randorf N; Ahsan H; Odunsi K; Madueke-Laveaux OS
Int J Environ Res Public Health; 2024 Feb; 21(2):. PubMed ID: 38397711
[TBL] [Abstract] [Full Text] [Related]
3. Solvent-free synthesis and
Shankar B; Singh T; Kumar B; Arora A; Kumar S; Singh BK
Org Biomol Chem; 2023 Dec; 21(47):9398-9409. PubMed ID: 37982163
[TBL] [Abstract] [Full Text] [Related]
4. Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination efforts.
Pimenoff VN; Gray P; Louvanto K; Eriksson T; Lagheden C; Söderlund-Strand A; Dillner J; Lehtinen M
Cell Host Microbe; 2023 Nov; 31(11):1921-1929.e3. PubMed ID: 37944494
[TBL] [Abstract] [Full Text] [Related]
5. Prognosis and adjuvant chemotherapy for patients with malignant peritoneal cytology in early-stage non-endometrioid endometrial cancer.
Tang X; Li N; Hu Y
Eur J Surg Oncol; 2023 Nov; 49(11):107071. PubMed ID: 37708662
[TBL] [Abstract] [Full Text] [Related]
6. Association Between Oncology Clinical Pathway Utilization and Toxicity and Cost Outcomes in Patients With Metastatic Solid Tumors.
Liu Y; Mullangi S; Debono D; Chen X; Pham T; Fisch MJ; Gordon AS; Hershman DL
JCO Oncol Pract; 2023 Sep; 19(9):731-740. PubMed ID: 37384847
[TBL] [Abstract] [Full Text] [Related]
7. A barrier to participation in cervical cancer screenings: fatalism.
Duru G; Topatan S
Women Health; 2023 Jul; 63(6):436-444. PubMed ID: 37303197
[TBL] [Abstract] [Full Text] [Related]
8. Identification of HOXB9 to predict prognosis of endometrial cancer based on comprehensive bioinformatics analysis.
Xu Y; Zhang M; Shi Q; Cheng X; Du R; Li C; Zhang Y
Eur J Med Res; 2023 Feb; 28(1):79. PubMed ID: 36803556
[TBL] [Abstract] [Full Text] [Related]
9. A novel somatic mutation in POLE exonuclease domain associated with ultra-mutational signature and MMR deficiency in endometrial cancer: a case report.
Cui J; Chen X; Zhai Q; Chen N; Li X; Zhang Y; Wang H; Bian X; Gao N; Chen D; Chen Z; Zhang S; Chen Y
Diagn Pathol; 2023 Feb; 18(1):19. PubMed ID: 36765365
[TBL] [Abstract] [Full Text] [Related]
10. Meta-Analysis of Survival Effects of Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1).
Jeong SY; Lee KJ; Cha J; Park SY; Kim HS; Kim JH; Lee JJ; Kim N; Park ST
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557069
[TBL] [Abstract] [Full Text] [Related]
11. Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT).
Vallely AJB; Saville M; Badman SG; Gabuzzi J; Bolnga J; Mola GDL; Kuk J; Wai M; Munnull G; Garland SM; Brotherton JML; Kelly-Hanku A; Morgan C; Toliman PJ; Kombati Z; Kariwiga G; Babona D; Tan G; Simms KT; Cornall AM; Tabrizi SN; Wand H; Guy R; Canfell K; Kaldor JM
Lancet Glob Health; 2022 Sep; 10(9):e1336-e1346. PubMed ID: 35878625
[TBL] [Abstract] [Full Text] [Related]
12. Radiological evaluation of metastatic lymph nodes in carcinoma cervix with emphasis on their infiltrative pattern.
Dhamija E; Baby A; Bhatla N; Pulappadi VP; Kumar M; Kumar S; Kumar L; Sharma D
Indian J Med Res; 2021 Aug; 154(2):383-390. PubMed ID: 35295016
[TBL] [Abstract] [Full Text] [Related]
13. Characterizing isolated tumor cells in regional lymph nodes of early endometrial cancer.
Matsuo K; Khetan VU; Brunette LL; Jooya ND; Klar M; Wright JD; Roman LD
Gynecol Oncol; 2022 May; 165(2):264-269. PubMed ID: 35232589
[TBL] [Abstract] [Full Text] [Related]
14. Socioeconomic disparities in endometrial cancer survival in Germany: a survival analysis using population-based cancer registry data.
Bedir A; Abera SF; Vordermark D; Medenwald D
J Cancer Res Clin Oncol; 2022 May; 148(5):1087-1095. PubMed ID: 35064816
[TBL] [Abstract] [Full Text] [Related]
15. Prediction of out-of-field recurrence after chemoradiotherapy for cervical cancer using a combination model of clinical parameters and magnetic resonance imaging radiomics: a multi-institutional study of the Japanese Radiation Oncology Study Group.
Ikushima H; Haga A; Ando K; Kato S; Kaneyasu Y; Uno T; Okonogi N; Yoshida K; Ariga T; Isohashi F; Harima Y; Kanemoto A; Ii N; Wakatsuki M; Ohno T
J Radiat Res; 2022 Jan; 63(1):98-106. PubMed ID: 34865079
[TBL] [Abstract] [Full Text] [Related]
16. Pattern of relapse in patients with stage IB1 cervical cancer after radical hysterectomy as primary treatment. Minimally invasive surgery vs. open approach. Systematic review and meta-analysis.
Manzour N; Núñez-Cordoba JM; Chiva L; Chacón E; Boria F; Vara-García J; Rodriguez-Velandia YP; Minguez JA; Alcazar JL
Gynecol Oncol; 2022 Feb; 164(2):455-460. PubMed ID: 34848071
[TBL] [Abstract] [Full Text] [Related]
17. Association between Early Menopause, Gynecological cancer, and Tobacco Smoking: A Cross-Sectional Study.
Kim JM; Yang YS; Lee SH; Jee SH
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3165-3170. PubMed ID: 34710992
[TBL] [Abstract] [Full Text] [Related]
18. The incidence of urologic complications requiring urologic procedure in radical hysterectomy and difference between abdominal radical hysterectomy and laparoscopic radical hysterectomy.
Kim H; Jeong HJ; Kim BW; Hwang JH
J Gynecol Oncol; 2021 Nov; 32(6):e84. PubMed ID: 34431255
[TBL] [Abstract] [Full Text] [Related]
19. Preoperative leukocytosis correlates with unfavorable pathological and survival outcomes in endometrial carcinoma: A systematic review and meta-analysis.
Abu-Zaid A; Alomar O; Baradwan S; Abuzaid M; Alshahrani MS; Allam HS; Alqarni SMS; Nazer A; Salem H; Al-Badawi IA
Eur J Obstet Gynecol Reprod Biol; 2021 Sep; 264():88-96. PubMed ID: 34298450
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of preoperative serum neopterin, periostin, indoleamine 2,3-dioxygenase, YKL-40, and tenascin-C levels with current tumor markers for early-stage endometrial cancer.
Unuvar S; Melekoglu R; Turkmen NB; Yilmaz E; Yasar S; Yuce H
Int J Gynaecol Obstet; 2021 Dec; 155(3):417-424. PubMed ID: 33660848
[TBL] [Abstract] [Full Text] [Related]
[Next]
